Company's Board of Directors Appoint James F. Parslow to Interim Chief Executive Officer FRAMINGHAM, MA / ACCESSWIRE / May 22, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company")
Xenetic Biosciences, Inc. Announces Executive Leadership Transition Company s Board of Directors Appoint James F. Parslow to Interim Chief Executive Officer .